Nephrocare Health Services Share Price Live
NEPHROPLUS
Live Nephrocare Health Services Share Price Chart
Nephrocare Health Services Performance
Days Range
| Previous Close | ₹683.10 |
|---|---|
| Open | ₹684.7 |
| Volume | 77,557 |
| Day's Range | ₹662.60 - ₹691.55 |
|---|---|
| 52W Range | ₹446.00 - ₹769.75 |
| Market Cap | ₹6,855.61 Cr |
Nephrocare Health Services Fundamentals
| ROCE(TTM) | 13.18 |
|---|---|
| P/E Ratio (TTM) | 89.23 |
| P/B Ratio | 6.14 |
| Industry P/E | 66.99 |
| Debt to Equity | 0.07 |
| ROE | 6.88 |
| EPS (TTM) | 7.45 |
| Dividend Yield | N/A |
| Book Value | 111.03 |
| Face Value | 2 |
| ROCE(TTM) | 13.18 |
|---|---|
| P/E Ratio (TTM) | 89.23 |
| P/B Ratio | 6.14 |
| Industry P/E | 66.99 |
| Debt to Equity | 0.07 |
| ROE | 6.88 |
|---|---|
| EPS (TTM) | 7.45 |
| Dividend Yield | N/A |
| Book Value | 111.03 |
| Face Value | 2 |
Nephrocare Health Services Financials
| Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|
| Net Sales | 219.19 | 245.72 | 259.73 | 265.62 |
| Expenses | 187.27 | 205.23 | 220.73 | 237.69 |
| Profit before tax | 29.92 | -0.62 | 36.36 | 33.22 |
| Operating Profit | 24.87 | -9.47 | 32.24 | 30.37 |
| Net Profit | 24.87 | -9.47 | 32.24 | 30.37 |
| EPS in Rs | 3.05 | -1.12 | 3.43 | 3.03 |
Nephrocare Health Services Shareholding Pattern
Promoters
63.85%
Retail And Others
18.32%
Foreign Institutional Investors
8.78%
Domestic Institutional Investors
9.05%
About Nephrocare Health Services
Nephrocare Health Services Limited was incorporated as 'Nephrocare Health Services Private Limited', a private limited company at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh on December 18, 2009. Company was converted into a public limited company and the name was changed to 'Nephrocare Health Services Limited' with a fresh certificate of incorporation dated June 18, 2025 issued by the Registrar of Companies, Central Registration Centre.
The Company set out to address critical gaps in dialysis care through better access, higher clinical standards and a patient-first approach. It provides comprehensive dialysis care through a network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy.
The Company the business in 2010 with the launch of its first dialysis clinic in Hyderabad. It launched first Public Private Partnership (PPP) clinic in Sananth Nagar, Hyderabad in 2012; acquired 100% stake in DaVita Care (India) Private Limited, the Indian arm of DaVita Care Pte Ltd. in 2018; launched operations in Philippines by acquiring Royal Care Dialysis Center, Inc in 2020.
The Company acquired 6 clinics dialysis network with 35000 annual tretaments in 2023 . Further, it has acquired a chain of 7 clinics dialysis network such as AIZ Hemodialysis Center Inc., Bioregen Hemo Center Inc., Carmona Dialysis System Inc., Infini Care Health Systems Inc., and Kolff Dialysis Inc. in FY25.
Company came up with the IPO by issuing 18,943,264 Equity Shares having the face value of Rs 2 each and raised funds aggregating to Rs 871.04 crore, comprising a fresh issue of 7,690,162 Equity Shares amounting to Rs 353.4 crore and the offer for sale of 11,253,102 Equity shares amounting to Rs 517.64 crore on December 12, 2025.
During FY 2026, Company built an integrated technology ecosystem that connects patients, clinicians, operations, and enterprise functions through cloud computing, artificial intelligence, automation, and data-driven insights. It further expanded the AI platform patient engagement, clinical workflows, operations, and business functions to scale the operations.
The Company served 1400+ guests across 6 clinics in 2026.
.
Parent Organisation
Indian Private
Managing Director
Vikram Vuppala
Founded
2009
NSE Symbol
NEPHROPLUS
Top Mutual Funds Invested in Nephrocare Health Services Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 8,957.0 -31.00 (-0.34%) | ₹1,28,759.16 | 6,696.5 - 9,036.5![]() |
| Max Healthcare Institute Ltd | 1,098.5 -26.30 (-2.34%) | ₹1,06,915.70 | 903.0 - 1,301.7![]() |
| Aster DM Quality Care Ltd | 822.15 8.15 (1.00%) | ₹71,638.40 | 519.1 - 839.4![]() |
| Fortis Healthcare Ltd | 945.0 -3.85 (-0.41%) | ₹71,328.45 | 766.8 - 1,104.3![]() |
| Narayana Hrudayalaya Ltd | 2,029.2 -51.10 (-2.46%) | ₹41,435.17 | 1,589.0 - 2,093.3![]() |
| Global Health Ltd | 1,405.6 -10.80 (-0.76%) | ₹37,867.90 | 956.0 - 1,456.5![]() |
Popular Stocks
Nephrocare Health Services Ltd FAQs
What is the share price of Nephrocare Health Services Ltd (NEPHROPLUS) shares?
Nephrocare Health Services Ltd (NEPHROPLUS) share price as of July 31, 2026, on NSE is Rs 681.65 (NSE) and Rs 681.65 (BSE) on BSE.
Can I buy Nephrocare Health Services Ltd (NEPHROPLUS) from Angel One?
Yes, You can buy Nephrocare Health Services Ltd (NEPHROPLUS) shares by opening a Demat account with Angel One.
How do I buy Nephrocare Health Services Ltd (NEPHROPLUS) from Angel One?
Nephrocare Health Services Ltd (NEPHROPLUS) share can be bought through the following modes:
1. Direct investment: You can buy Nephrocare Health Services Ltd (NEPHROPLUS) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Nephrocare Health Services Ltd (NEPHROPLUS) shares.
1. Direct investment: You can buy Nephrocare Health Services Ltd (NEPHROPLUS) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Nephrocare Health Services Ltd (NEPHROPLUS) shares.





